During the past decade, Ospedale Fatebenefratelli conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 2 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale Fatebenefratelli" #1 sponsor was "National Cancer Institute, Naples" with 5 trials, followed by "Fatebenefratelli Hospital" with 2 trials sponsored, "Associazione Progetto Oncologia UMAN.A" with 1 trials sponsored, "Careggi Hospital" with 1 trials sponsored and "Celgene" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Fatebenefratelli" #1 collaborator was "Mario Negri Institute for Pharmacological Research" with 3 trials as a collaborator, "University of Parma" with 2 trials as a collaborator, "Acibadem City Clinic Tokuda Hospital" with 1 trials as a collaborator, "Antwerp University Hospital, Edegem, Belgium" with 1 trials as a collaborator and "Association for Public Health "Salute Pubblica", Brindisi, Italy" with 1 trials as a collaborator. Other collaborators include 77 different institutions and companies that were collaborators in the rest 87 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale Fatebenefratelli" are "Ovarian Cancer" (4 trials), "Coronary Artery Disease" (2 trials), "Heart Failure" (2 trials), "Hypertrophic Cardiomyopathy" (2 trials) and "Acute Kidney Injury" (1 trials). Many other conditions were trialed in "Ospedale Fatebenefratelli" in a lesser frequency.

Most popular intervention types in "Ospedale Fatebenefratelli" are "Drug" (13 trials), "Procedure" (3 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Gemcitabine" (2 trials), "carboplatin" (2 trials), "paclitaxel" (2 trials), "ABCDE-Stress Echo" (1 trials) and "Apixaban" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Fatebenefratelli" are 12 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Ospedale Fatebenefratelli". undefined are not yet recruiting, 5 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Ospedale Fatebenefratelli, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Fatebenefratelli, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

Ospedale Fatebenefratelli has several departments that took part in Clinical trials: "Ospedale Fatebenefratelli, U.O. di Oncologia" - 7 trials